PTEN and Cowden syndrome 1: The mutation of phosphatase and tensin homolog (PTEN), the primary negative regulator of PI3K/Akt signaling, are detected in more than 70% of patients with the Cowden syndrome (CS), and these patients are at increased risk for breast, endometrial, thyroid, and renal carcinomas [12].